Company Filing History:
Years Active: 2015
Title: Yiwei Fu - Innovator in Androgen Receptor Degradation
Introduction
Yiwei Fu is an inventor based in Chengdu, CN. He is known for his innovative work in the field of biochemistry, particularly focusing on compounds that target androgen receptors. His research aims to develop effective treatments for prostate and breast cancers.
Latest Patent Applications
Yiwei Fu has submitted a patent application titled "BIFUNCTIONAL CHIMERIC HETEROCYCLIC COMPOUND AND USE THEREOF AS ANDROGEN RECEPTOR DEGRADER." This application describes a compound that can significantly down-regulate mutated androgen receptor (AR) proteins. The compound is characterized by a complex structure that includes a target recognition/binding portion, a linking portion, and a ubiquitin protease recognition/binding portion. The application highlights the compound's potential for use in preparing a protein degradation targeted chimera for the regulation of androgen receptors. It also emphasizes the promising application prospects in developing drugs for treating prostate and breast cancers.
Conclusion
Yiwei Fu's contributions to the field of androgen receptor degradation represent a significant step forward in cancer treatment research. His innovative approach and ongoing work in this area hold great promise for future therapeutic developments.